NCT00363090 2013-09-20Alemtuzumab and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV T-Cell Non-Hodgkin's LymphomaNational Cancer Institute (NCI)Phase 1/2 Unknown84 enrolled
NCT00562068 2013-08-26Alemtuzumab and Combination Chemotherapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IV Peripheral T-Cell LymphomaNational Cancer Institute (NCI)Phase 1 Unknown30 enrolled
NCT00740467 2010-01-28Stem Cell Transplant in Treating Patients With Hematological Cancer or Other DisordersNational Cancer Institute (NCI)Phase 2 Unknown50 enrolled